Despite the possibility of APOL1 exacerbating cardiometabolic conditions, no in-vivo experimental studies have been conducted to investigate the direct role of APOL1 in obesity. This evidence concerns the gene APOL1 and obesity due to melanocortin 4 receptor deficiency.